DrugId:  1
1. Name:  Denileukin diftitox
2. Groups:  Approved, Investigational
3. Description:  A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.
4. Indication:  For treatment of cutaneous T-cell lymphoma
DrugId:  2
1. Name:  Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved, Investigational
3. Description:  Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 4 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  3
1. Name:  Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen
2. Groups:  Approved
3. Description:  Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains N. meningitis serogroup W-135 capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
4. Indication:  Not Available
DrugId:  4
1. Name:  Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 9v individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  5
1. Name:  Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen
2. Groups:  Approved, Investigational
3. Description:  Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
4. Indication:  Not Available
DrugId:  6
1. Name:  Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 1 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  7
1. Name:  Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 3 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  8
1. Name:  Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen
2. Groups:  Approved
3. Description:  Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup c. The vaccine contains N. meningitis serogroup c capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
4. Indication:  Not Available
DrugId:  9
1. Name:  Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 14 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  10
1. Name:  Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 5 individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  11
1. Name:  Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen
2. Groups:  Approved
3. Description:  Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains* N. meningitis* serogroup y capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
4. Indication:  Not Available
DrugId:  12
1. Name:  Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 19f individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  13
1. Name:  Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 18c individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  14
1. Name:  Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 23f individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  15
1. Name:  Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 7f individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  16
1. Name:  Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 19a individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  17
1. Name:  Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 6b individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197) . It is contained in the vaccine under the market name Prevnar that contains the saccharides for serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F for intramuscular injection. The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
DrugId:  18
1. Name:  Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 6a individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
4. Indication:  Not Available
